<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">411</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 479.160 L104.610 479.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="76.959" x="109.054,114.058,117.055,121.051,124.048,127.549,132.049,136.045,140.041,142.543,145.54,148.042,152.038,156.538,158.788,159.742,163.243,167.743,174.745,181.747,185.743,190.243,192.493,193.447,196.948,200.944,205.444,208.441,212.437,214.687,215.641,219.637,224.137,228.133,230.635,235.135,238.636,242.632,246.133,248.383,249.337,253.333,256.834,259.336,261.838,268.84,272.836,275.338,279.334,283.834,286.084,287.038,289.54,294.04,298.036" svgx:width="0.56,0.33,0.44,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.39,0.5,0.78,0.78,0.44,0.5,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25,0.55,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Pre-specified summed score analyses estimated the </text>
   <text y="87.957" x="62.362,70.363,76.366,79.363,85.861,88.363,94.366,100.864,103.321,105.823,110.323,113.32,117.316,120.817,125.317,129.817,132.319,136.819,139.276,142.273,146.773,149.77,152.227,154.729,159.229,161.731,165.727,168.724,173.224,176.221,180.217,182.719,185.221,189.721,194.221,196.678,199.18,203.68,208.18,210.682,215.182,217.684,222.184,226.684,230.68,233.182,235.639,239.635,244.135,248.131,252.631,257.131,261.127,263.584,268.084,272.584,276.58,279.577,282.034,284.536,287.038,294.04,298.036" svgx:width="0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.25,0.28,0.28,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MCID/RD threshold for interpreting individual change over time </text>
   <text y="98.955" x="62.362,66.862,71.362,73.612,76.69,79.192,83.692,87.688,89.938,93.016,101.017,106.021,114.517,119.521,122.518,127.018,131.518,133.768,136.846,139.348,143.848,146.098,149.176,157.177,162.181,164.431,167.509,172.009,176.005,178.507,181.009,185.005,189.505,192.007,195.508,197.758,200.836,207.334,209.836,212.338,216.838,219.088,222.166,228.664,232.66,235.162,239.662,242.164,246.664,251.164,253.414,256.492,258.994,265.996,270.496,274.492,276.994,279.991,286.993,290.989,295.489,297.991" svgx:width="0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on the MSWS-12 in MS patients with walking impairment </text>
   <text y="109.953" x="62.362,65.359,69.859,73.855,76.852,79.354,83.854,87.85,92.35,94.6,95.5,99.496,102.997,105.247,106.147,110.647,114.643,119.143,121.645,126.145,130.645,132.895,133.795,137.791,141.292,143.542,144.442,149.941,154.441,158.941,162.937,167.437,171.937,175.933,180.433,182.683,183.583,190.081,192.583,196.084,200.08,204.58,207.082,209.584,212.086,214.588,219.088,221.338,222.238,227.242,229.744,233.74,236.242,240.742,244.243,246.493,247.393,252.397,256.393,260.389,262.891,266.887,269.137,270.037,273.034,278.533,285.031,290.035,295.039,298.036" svgx:width="0.33,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.56,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(defined as having as Expanded Disability Status Scale (EDSS) </text>
   <text y="120.951" x="62.362,65.863,69.859,74.359,77.356,81.352,83.908,88.408,91.405,93.961,98.461,101.458,105.958,108.955,111.511,116.011,120.007,123.004,125.506,128.008,132.004,134.506,139.006,143.002,145.504,148.006,152.506,157.006,159.562,162.064,166.564,169.12,171.622,176.122,180.118,182.674,187.174,191.674,194.671,201.169,205.165,209.161,213.661,216.217,220.717,225.217,229.717,234.217,236.719,240.715,243.712,248.212,250.714,253.216,257.716,262.216,264.466,267.022,271.522,274.024,278.02,282.016,286.012,290.512,295.012" svgx:width="0.39,0.44,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">score of 4-7) participating in the 24-week double-blind, placebo-</text>
   <text y="131.949" x="62.362,66.358,70.858,75.358,77.86,80.857,85.357,87.859,90.361,94.357,98.857,101.107,103.357,106.354,110.35,114.85,119.35,123.85,130.852,133.354,137.35,141.346,145.846,148.096,156.097,162.595,168.598,171.595,177.094,182.593,184.843,187.345,190.342,192.844,196.84,199.342,201.592,206.092,209.089,211.339,214.336,218.332,225.334,229.834,232.831,235.333,239.833,242.335,246.835,250.831,253.828,258.832,264.835" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.89,0.72,0.67,0.33,0.61,0.61,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controlled, randomized MOBILE trial of fampridine-PR.</text>
   <text y="142.947" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="142.947" x="101.917,107.92,112.42,114.922,119.422,121.672,122.482,126.478,130.978,134.974,139.474,143.974,146.791,149.788,152.038,152.848,156.844,161.344,165.844,168.094,168.904,173.404,175.906,179.407,181.909,184.906,187.408,191.908,196.408,198.91,201.412,205.912,210.412,213.409,217.909,221.905,225.406,229.402,233.902,236.152,236.962,240.958,245.458,249.958,252.955,257.455,261.451,265.447,269.947,273.943,277.444,279.694,280.504,287.002,290.998,293.995,297.991" svgx:width="0.67,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.33,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Both anchor- and distribution-based approaches were </text>
   <text y="153.945" x="62.362,66.862,70.363,74.359,78.859,81.001,83.503,88.003,90.145,94.141,97.642,100.144,102.646,109.648,113.644,116.146,120.142,122.284,124.786,129.286,133.282,135.424,143.425,149.428,152.425,158.923,161.425,167.428,173.926,176.068,180.568,184.069,186.571,191.071,195.571,197.713,200.215,204.715,208.711,210.853,215.353,219.349,221.851,225.847,227.989,231.985,236.485,238.987,241.489,245.485,249.481,251.983,255.979,260.479,262.621,266.617,269.119,271.099,278.875,282.871,286.867,291.367,293.509,298.009" svgx:width="0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.94,0.44,0.44,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">used to estimate the MCID/RD using the data collected at Week 2 </text>
   <text y="164.943" x="62.362,66.358,70.858,75.358,77.941,81.937,84.439,87.022,90.523,95.023,99.523,103.024,107.02,111.52,116.02,120.016,124.516,127.018,129.601,136.603,141.103,145.603,148.105,152.605,155.107,159.607,162.19,166.186,170.686,177.688,180.19,184.69,187.192,190.693,193.195,196.192,200.188,202.69,205.192,209.692,214.192,217.693,220.276,224.776,227.773,230.356,232.858,237.358,241.354,243.937,251.938,256.942,265.438,270.442,273.439,277.939,282.439,285.022,289.018,293.518,298.018" svgx:width="0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and at subsequent monthly administrations of the MSWS-12 and </text>
   <text y="175.941" x="62.362,66.862,69.364,73.864,77.86,80.857,83.683,90.181,94.177,96.679,101.179,103.681,108.181,112.681,115.678,118.675,122.671,125.173,129.169,131.671,135.667,140.167,142.993,146.989,151.489,155.989,160.489,164.989,167.491,171.991,174.493,177.994,180.82,183.322,187.822,190.648,198.649,205.147,211.15,214.147,219.646,225.145,227.395,230.221,236.224,240.22,242.722,246.718,251.218,255.214,259.714,262.216,265.042,267.544,274.546,279.046,282.043,286.543,291.043,295.039" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.89,0.72,0.67,0.33,0.61,0.61,0.25,0.25,0.67,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other walking-related endpoints in MOBILE. Relevant improve-</text>
   <text y="186.939" x="62.362,69.364,73.36,77.86,80.362,83.863,86.428,90.928,95.428,97.93,100.495,104.995,107.992,110.557,113.059,117.559,121.555,124.12,129.124,133.12,135.622,138.124,142.12,146.62,149.122,151.687,158.185,160.687,165.187,169.687,173.683,176.185,178.75,181.747,188.749,193.249,196.246,200.242,203.743,207.244,209.746,214.246,218.746,221.311,225.811,228.808,231.373,237.376,241.876,245.872,250.372,254.872,258.868,261.433,265.429,269.929,274.429,276.994,281.494,284.491,287.056,289.558,294.058,298.054" svgx:width="0.78,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.72,0.28,0.5,0.5,0.44,0.28,0.25,0.33,0.78,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.5,0.44,0.5,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ments on: 1) the Patient Global Impression of Change and 2) the </text>
   <text y="197.937" x="62.362,67.861,72.361,75.358,79.858,86.356,90.856,93.358,96.355,100.855,107.353,110.35,114.85,120.016,122.266,123.517,130.519,135.019,139.519,142.021,144.523,147.025,149.527,154.027,156.277,157.528,162.028,166.528,170.524,174.025,176.527,179.029,183.529,188.029,190.279,191.53,198.028,202.024,205.021,209.017,211.267,212.518,216.019,220.015,222.517,226.513,230.509,233.011,237.007,241.507,243.757,245.008,249.004,252.505,254.755,256.006,260.002,264.502,268.498,272.998,277.498,280.495,283.996,286.246,287.497,290.494,294.994,297.991" svgx:width="0.61,0.5,0.33,0.5,0.72,0.5,0.28,0.33,0.5,0.72,0.33,0.5,0.61,0.25,0.55,0.78,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.33,0.39,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EuroQol-5D-5L mobility question were selected as anchors for </text>
   <text y="208.935" x="62.362,66.358,69.859,72.361,74.863,81.865,85.861,88.363,90.865,95.365,99.865,102.115,104.302,106.804,111.304,115.3,117.55,119.737,127.738,133.741,136.738,143.236,145.738,151.741,158.239,160.489,162.676,167.176,170.173,172.423,174.61,177.112,181.612,185.608,187.858,190.045,198.046,203.05,211.546,216.55,219.547,224.047,228.547,230.797,233.047,235.072,240.571,245.071,249.067,251.317,253.504,258.004,260.506,264.007,266.509,269.506,272.008,276.508,281.008,283.51,286.012,290.512,295.012" svgx:width="0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">estimating the MCID/RD of the MSWS-12. The distribution-</text>
   <text y="219.933" x="62.362,66.862,70.858,74.359,78.355,82.855,85.474,89.47,92.971,95.473,97.975,104.977,108.973,111.475,115.471,118.09,122.59,125.587,128.206,130.708,135.208,139.204,141.823,149.824,155.827,158.824,165.322,167.824,173.827,180.325,182.944,189.442,193.438,196.939,199.558,202.06,206.56,210.556,213.175,216.676,219.178,223.174,227.674,232.174,236.17,239.167,243.667,246.286,250.282,253.279,256.276,260.776,263.773,266.392,270.892,273.889,276.508,283.51,287.506,291.502,295.003" svgx:width="0.5,0.44,0.39,0.44,0.5,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.44,0.33,0.33,0.5,0.33,0.25,0.5,0.33,0.25,0.78,0.44,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">based estimate of the MCID/RD was the standard error of meas-</text>
   <text y="230.931" x="62.362,66.862,69.859,73.855,80.857,84.853,89.353,91.855,94.105,97.426,100.423,105.427,110.926,118.927,121.924,124.174,126.424,129.745,132.742,135.244,139.24,142.237,146.233,148.735,151.237,155.737,159.733,161.983,165.304,169.3,173.8,180.802,185.302,189.298,192.295,194.797,198.298,202.798,207.298,210.799,213.049,216.37,219.367,221.869,224.866,227.368,231.364,235.864,240.364,244.864,247.366,251.362,253.864,256.366,260.866,265.366,268.363,270.613,273.934,278.434,281.431,283.681,287.002,289.504,294.004,298.0" svgx:width="0.5,0.33,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.56,0.61,0.89,0.33,0.25,0.25,0.55,0.33,0.28,0.44,0.33,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.39,0.25,0.55,0.33,0.28,0.33,0.28,0.44,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">urement (SEM). Iterative comparisons (triangulation) of the </text>
   <text y="241.929" x="62.362,66.358,70.858,74.854,79.354,83.854,86.671,89.668,92.224,96.22,100.72,105.22,107.776,112.276,114.778,118.279,120.781,123.778,126.28,130.78,135.28,137.782,140.284,144.784,149.284,152.281,156.781,160.777,164.278,168.274,172.774,175.33,179.326,182.827,185.329,187.831,194.833,198.829,201.331,205.327,208.828,211.384,217.882,220.384,222.886,227.386,229.942,234.442,238.942,242.443,246.439,249.436,253.936,257.932,262.432,264.988,269.488,272.485,276.481,280.477,284.977,288.478,291.034,293.536,298.036" svgx:width="0.44,0.5,0.44,0.5,0.5,0.33,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anchor- and distribution-based estimates with observed breaks in </text>
   <text y="252.927" x="62.362,66.862,69.364,71.866,76.366,80.866,84.862,89.362,91.531,95.527,100.027,104.023,108.523,113.023,117.019,119.188,122.689,126.685,131.185,134.182,138.178,140.347,144.847,148.843,151.345,155.341,157.51,160.507,163.504,168.004,175.006,177.175,179.677,184.177,188.173,190.342,198.343,204.841,210.844,213.841,219.34,224.839,227.008,229.51,232.507,235.009,239.005,241.507,243.676,247.672,250.174,252.676,257.176,263.674,267.67,272.17,274.339,277.336,281.836,284.833,287.002,289.504,294.004,298.0" svgx:width="0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.89,0.72,0.67,0.33,0.61,0.61,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.44,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">blinded change score data from the MOBILE trial allowed for the </text>
   <text y="263.925" x="62.362,66.358,69.859,72.361,74.863,81.865,85.861,88.363,90.865,95.365,99.865,102.115,106.615,109.612,111.862,115.858,118.108,121.609,124.111,128.611,133.111,135.613,139.609,141.859,146.359,150.355,153.856,156.358,158.608,163.108,167.104,169.606,174.106,178.102,180.352,183.349,187.849,190.846,193.096,195.598,200.098,204.094,206.344,214.345,220.348,223.345,229.843,232.345,238.348,244.846" svgx:width="0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.39,0.28,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">estimation of a single best value for the MCID/RD.</text>
   <text y="274.923" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="274.923" x="98.002,103.501,108.001,111.997,114.247,116.641,120.637,125.137,129.133,133.633,138.133,140.95,143.947,148.447,152.443,155.944,159.94,164.44,166.69,169.084,176.086,180.082,182.584,187.084,191.584,196.084,199.585,201.835,204.229,208.729,211.231,215.227,217.729,222.229,226.225,230.725,232.975,235.369,242.371,246.367,250.867,253.369,257.365,261.865,264.115,266.509,270.505,275.005,279.001,283.501,288.001,291.997,295.498" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.33,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.78,0.44,0.28,0.5,0.5,0.5,0.39,0.25,0.55,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The anchor-based methods yielded median changes/</text>
   <text y="285.921" x="62.362,65.359,69.355,73.855,78.355,82.351,84.853,87.355,91.855,96.355,99.856,102.07,106.57,110.566,113.068,119.566,123.562,127.558,132.058,134.272,138.772,141.022,145.522,147.736,151.732,156.232,160.732,162.946,167.446,169.696,174.196,176.41,180.91,185.41,187.912,192.412,194.914,198.415,200.629,205.129,209.629,211.843,214.345,218.845,222.841,225.055,233.056,238.06,246.556,251.56,254.557,259.057,263.557,265.771,268.768,273.268,276.265,278.479,281.98,288.982,292.978,295.48,297.982" svgx:width="0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.39,0.78,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reductions between 5.2 and 9.7 points on the MSWS-12 for small </text>
   <text y="296.919" x="62.362,66.862,71.362,73.864,76.114,76.816,79.318,86.32,90.82,95.32,98.317,100.819,104.815,109.315,111.817,114.067,114.769,118.765,123.265,127.261,131.761,136.261,140.257,143.758,146.008,146.71,149.212,153.712,155.962,156.664,163.162,167.158,169.66,174.16,176.662,181.162,185.662,187.912,188.614,192.61,197.11,199.612,202.114,204.616,207.118,211.033,213.283,216.073,221.572,226.072,230.068,232.318,233.02,237.52,240.022,243.523,246.025,249.022,251.524,256.024,260.524,263.026,265.528,270.028,274.528,277.525,282.025,286.021,289.522,293.518,298.018" svgx:width="0.5,0.5,0.28,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but important changes in walking ability. The distribution-based </text>
   <text y="307.917" x="62.362,70.363,76.366,79.363,85.861,88.363,94.366,100.864,102.952,106.948,110.449,112.951,115.453,122.455,126.451,128.953,132.949,135.037,141.535,145.531,149.032,151.12,155.62,157.87,162.37,164.458,168.958,173.458,175.96,180.46,182.962,186.463,188.56,191.557,196.057,200.557,204.553,206.641,211.645,217.144,225.145,228.142,230.392,232.327,237.826,242.326,245.323,249.823,254.323,258.823,263.323,265.411,267.913,272.413,276.409,278.497,280.999,283.996,286.498,290.494,294.994" svgx:width="0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.25,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.44,0.25,0.56,0.61,0.89,0.33,0.25,0.25,0.61,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MCID/RD estimate was 6.8 points (one SEM). Through the trian-</text>
   <text y="318.915" x="62.362,66.862,71.362,73.864,77.86,80.362,82.864,87.364,91.864,94.114,95.104,99.604,102.601,107.101,111.097,115.093,118.594,122.095,124.345,126.595,127.585,131.581,133.831,134.821,137.818,141.814,146.314,150.814,154.81,157.312,159.814,164.314,168.814,171.064,172.054,176.554,179.551,181.801,182.791,187.291,189.541,190.531,195.031,199.531,202.033,206.533,209.035,212.536,214.786,215.776,220.276,224.776,227.026,228.016,230.518,235.018,239.014,241.264,242.254,250.255,255.259,263.755,268.759,271.756,276.256,280.756,283.006,283.996,290.494,294.49,297.991" svgx:width="0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.25,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gulation process, a reduction of 8 points on the MSWS-12 was </text>
   <text y="329.913" x="62.362,65.863,69.859,72.361,76.357,80.353,82.855,86.851,91.351,93.601,97.597,101.098,103.348,105.85,110.35,114.346,116.596,121.096,125.092,128.593,131.095,133.345,137.341,140.842,143.344,145.846,152.848,156.844,159.346,163.342,165.592,170.092,173.089,175.339,177.841,182.341,186.337,188.587,196.588,202.591,205.588,212.086,214.588,220.591,227.089,229.339,231.841,236.341,238.591,241.093,245.593,249.589,253.09,257.086,259.336,263.836,267.832,270.334,272.836,276.832,281.332,283.834,287.335" svgx:width="0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.39,0.28,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.67,0.33,0.72,0.28,0.67,0.72,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">selected as the best estimate of the MCID/RD in these patients.</text>
   <text y="340.911" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="340.911" x="113.833,119.332,123.832,127.828,131.329,135.325,137.287,140.284,142.786,147.286,151.786,154.288,158.788,163.288,166.789,168.751,171.253,175.753,180.253,182.755,186.751,190.747,193.249,197.245,199.198,201.7,206.2,210.196,212.698,214.66,218.656,223.156,225.118,229.618,232.615,237.115,241.615,244.117,248.617,251.119,253.081,256.078,260.074,264.574,269.074,273.07,275.572,278.074,282.574,287.074,289.027,293.527,298.027" svgx:width="0.61,0.5,0.44,0.39,0.44,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">These findings indicate that an 8-point reduction on </text>
   <text y="351.909" x="62.362,64.864,69.364,73.36,75.61,77.815,85.816,90.82,99.316,104.32,107.317,111.817,116.317,118.567,120.772,125.272,128.269,132.769,137.269,139.771,144.271,148.267,151.768,154.018,156.223,160.219,162.469,164.674,167.671,171.667,175.663,179.164,183.664,188.164,192.16,196.66,199.162,203.158,205.408,207.613,210.115,214.615,217.612,221.608,225.109,229.609,234.109,236.611,241.111,243.361,245.566,248.563,253.063,256.06,258.31,260.515,264.511,268.012,270.514,273.016,280.018,284.014,286.516,289.018,293.518,298.018" svgx:width="0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.44,0.39,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the MSWS-12 provides a reasonable threshold for estimating </text>
   <text y="362.907" x="62.362,68.86,73.36,77.356,79.858,84.358,88.354,91.351,93.538,97.534,102.034,104.221,112.222,117.226,119.413,122.914,127.414,131.914,134.416,138.412,142.408,144.91,147.097,153.595,156.097,158.599,163.099,165.286,171.784,175.78,178.282,182.782,185.284,189.784,194.284,196.471,198.973,205.975,210.475,214.471,216.973,219.97,226.972,230.968,235.468,237.97,240.157,243.154,247.654,251.65,254.647,257.149,261.649,265.645,270.145,272.332,276.328,279.829,282.016,286.516,290.512,295.012" svgx:width="0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.25,0.89,0.56,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">whether an MS subject with walking impairment (defined as hav-</text>
   <text y="373.905" x="62.362,64.864,69.364,73.864,76.294,80.29,84.79,87.22,92.719,99.217,104.221,109.225,111.655,116.155,120.151,122.653,129.151,133.147,137.143,141.643,144.073,148.573,151.003,154.999,159.499,163.999,166.429,170.929,173.926,176.356,180.352,184.852,187.849,192.349,194.851,197.353,201.349,205.849,208.279,210.781,215.281,217.711,220.213,224.713,228.709,231.139,239.14,245.638,251.641,254.638,260.137,265.636,268.066,270.568,273.565,276.067,280.063,282.565,284.995,289.495,293.491,297.991" svgx:width="0.28,0.5,0.5,0.25,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.72,0.67,0.33,0.61,0.61,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing an EDSS between 4 and 7) enrolled in the MOBILE trial had </text>
   <text y="384.903" x="62.362,66.358,70.858,75.358,79.354,82.351,84.853,88.849,93.349,97.345,101.341,105.841,107.731,111.727,113.617,120.619,124.615,128.611,133.111,135.613,140.113,144.613,147.61,152.11,154.612,156.502,159.004,166.006,170.506,173.503,178.003,182.503,186.499,193.501,197.497,201.997,204.499,206.389,208.891,213.391,215.281,217.783,222.283,226.279,228.781,231.778,233.668,237.169,241.165,243.667,246.664,249.661,252.658,256.654,261.154,265.654,268.651,271.153,275.149,279.649,281.539,285.535,290.035,292.537,295.039" svgx:width="0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.5,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.28,0.5,0.5,0.33,0.5,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.39,0.44,0.28,0.33,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">experienced a meaningful improvement in their self-reported abil-</text>
   <text y="395.901" x="62.362,64.864,67.366,71.866,74.467,76.969,81.469,84.07,90.568,94.564,97.066,101.566,104.167,108.667,113.167,117.163,120.16,122.761,127.261,131.761,134.362,140.86,144.856,148.852,153.352,156.853,159.103,161.542,167.041,171.541,175.537,178.138,182.638,186.634,191.134,195.13,198.127,202.123,204.625,207.127,211.123,215.119,219.619,222.121,224.623,227.125,229.627,234.127,236.728,241.228,244.225,246.826,249.328,253.828,256.33,259.831,262.432,265.429,267.931,272.431,276.931,279.433,283.933,288.433,291.034,293.536,298.036" svgx:width="0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.72,0.44,0.28,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.44,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity to walk over 24 weeks. The generalizability of this finding to </text>
   <text y="406.899" x="62.362,66.862,69.364,73.864,77.86,80.857,83.107,83.881,91.882,96.886,99.136,99.91,104.41,108.406,110.908,113.41,117.406,121.906,124.408,127.909,130.159,132.409,133.183,136.684,141.184,145.18,149.68,151.93,152.704,156.7,160.201,162.451,163.225,165.727,170.227,174.727,178.228,182.224,184.474,185.248,191.746,194.248,196.75,201.25,203.5,204.274,211.276,213.778,216.28,220.78,224.776,227.773,230.023,230.797,237.295,241.291,243.793,248.293,250.795,255.295,259.795,262.045,262.819,267.319,269.821,273.322,277.318,281.818,284.32,286.822,289.324,291.826,295.741,297.991" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.28,0.5,0.5,0.39,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.28,0.28,0.5,0.44,0.33,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other MS patients, such as those with milder walking disability, </text>
   <text y="417.897" x="62.362,66.358,70.858,75.358,77.608,82.108,84.61,89.11,93.106,96.103,98.353,101.854,104.356,108.856,113.356,115.858,119.854,123.355,125.605,127.855,132.355,136.351,139.852,143.848,146.845,151.345,155.341,158.842,161.092,164.089,168.589,171.091,175.591,178.588,182.584,184.834,187.336,191.836,196.336,200.332,203.833,206.335,208.837,213.337,217.333,219.835,222.337,226.837,231.337" svgx:width="0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.5,0.44,0.39,0.44,0.33,0.5,0.44,0.39,0.25,0.33,0.5,0.28,0.5,0.33,0.44,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and other studies, deserves future investigation.</text>
   <text y="444.897" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P784</text>
   <text y="455.895" x="62.362,67.861,71.362,75.862,79.858,84.862,89.362,96.859,100.855,103.852,107.848,110.35,114.346,116.596,119.593,123.589,127.09,130.087,132.589,137.593,142.093,144.343,148.843,151.84,154.09,157.087,162.091,166.087,168.337,172.333,176.833,180.829,183.331,187.831,190.081,197.578,202.078,207.082,209.584,212.086,214.588,217.585,222.085,224.335,226.837,234.334,239.338,243.838,246.34,250.336,257.833,261.829,266.833,269.83" svgx:width="0.61,0.39,0.5,0.44,0.56,0.5,0.83,0.44,0.33,0.44,0.28,0.44,0.25,0.33,0.44,0.39,0.33,0.28,0.56,0.5,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.25,0.83,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.28,0.83,0.56,0.5,0.28,0.44,0.83,0.44,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Psychometric testing of the early mobility impairment </text>
   <text y="466.893" x="62.362,67.366,72.37,76.366,79.867,82.864,85.366,89.866,94.87,99.874,104.374,106.876,110.872,114.868,117.118,120.115,124.615,128.611,130.861,138.358,143.362,145.864,148.861,151.363,156.367,158.869,162.865,165.115,168.616,172.612,175.114,179.11,183.106,187.606,191.107,193.609" svgx:width="0.56,0.56,0.44,0.39,0.33,0.28,0.5,0.56,0.56,0.5,0.28,0.44,0.44,0.25,0.33,0.5,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">questionnaire for multiple sclerosis</text>
   <text y="477.891" x="62.362,67.861,70.111,75.61,78.112,82.108,89.11,92.611,96.112,100.108" svgx:width="0.61,0.25,0.61,0.28,0.44,0.78,0.39,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T Ziemssen</text>
   <text y="475.439" x="104.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="477.959" x="107.533,109.783,112.033,118.531,120.781,128.782,132.778,135.28,139.78,142.282,146.278" svgx:width="0.25,0.25,0.72,0.25,0.89,0.44,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Mathias</text>
   <text y="475.439" x="149.778" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="477.959" x="152.703,154.953,157.203,163.206,165.456,171.459,175.959,180.459" svgx:width="0.25,0.25,0.67,0.25,0.67,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Coon</text>
   <text y="475.439" x="184.959" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="477.959" x="187.884,190.134,192.384,197.388,199.638,206.136,210.636,214.632,217.629,224.127,228.123" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.44,0.33,0.72,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Agarwal</text>
   <text y="475.439" x="230.624" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="477.959" x="233.549,235.799,238.049,244.052,246.302,251.306,255.806,259.802" svgx:width="0.25,0.25,0.67,0.25,0.56,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Shah</text>
   <text y="475.439" x="264.302" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="477.959" x="267.227,269.477,271.727,278.225" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G </text>
   <text y="488.957" x="62.36,67.364,71.864,74.366,76.868,79.37,81.872,86.372" svgx:width="0.56,0.5,0.28,0.28,0.28,0.28,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Phillips</text>
   <text y="486.439" x="89.875" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="497.437" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="499.959" x="65.287,71.29,75.286,79.786,82.288,86.284,89.785,92.035,96.535,99.037,101.287,107.29,109.792,112.294,116.794,119.296,123.292,127.792,130.294,132.544,138.547,142.543,147.043,150.544,155.044,158.545,162.541,165.043,169.039,173.539,177.535,181.531,183.781,186.031,192.529,196.03,200.026,203.527,208.027,212.023,216.523,218.773,221.023,227.521,231.517,235.018,241.516,246.016,250.516,254.512,256.762" svgx:width="0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Center of Clinical Neuroscience, Dresden, Germany, </text>
   <text y="497.439" x="259.01" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="499.959" x="261.935,267.434,271.934,275.93,278.432,282.932,287.432,289.934" svgx:width="0.61,0.5,0.44,0.28,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Adelphi </text>
   <text y="510.957" x="62.36,67.859,72.359,74.861,79.361,83.357,86.858,89.108,91.358,96.857,101.357,104.858,107.36,111.86,116.36,118.61,120.86,128.357,133.856,136.106,138.356,144.854,149.354,151.856,154.358,158.354,162.854,165.104,169.604,172.106,176.606,179.108,183.104,186.605,188.855" svgx:width="0.61,0.5,0.28,0.5,0.44,0.39,0.25,0.25,0.61,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Values, Boston, MA, United States, </text>
   <text y="508.439" x="191.106" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="510.959" x="194.031,199.53,202.032,206.532,211.032,215.028,219.528,221.778,224.775,229.275,233.271,237.267,239.517,241.767,247.77,252.27,258.768,263.268,266.769,269.271,273.771,278.271,282.267,284.517" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Cambridge, </text>
   <text y="521.957" x="62.361,69.858,75.357,77.607,79.857,86.355,90.855,93.357,95.859,99.855,104.355,106.605,111.105,113.607,118.107,120.609,124.605,128.106,130.356" svgx:width="0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MA, United States, </text>
   <text y="519.439" x="132.607" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="521.959" x="135.532,142.03,146.53,149.032,153.028,157.024,160.525,164.026,166.528,169.03,173.026,175.276,179.776,182.278,184.528,192.025,194.527,198.028,201.529,204.031,207.532,211.033,213.535,218.035,222.535,225.037,227.287,229.537,236.035,240.535,243.037,247.033,251.029,254.53,258.031,260.533,263.035,267.031,269.281,271.531,279.028,283.528,285.778" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.28,0.39,0.39,0.28,0.39,0.39,0.28,0.5,0.5,0.28,0.25,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.83,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Mississippi, University, MS, </text>
   <text y="532.957" x="62.362,68.86,73.36,75.862,78.364,82.36,86.86,89.11,93.61,96.112,100.612,103.114,107.11" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States</text>
   <text y="559.957" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="559.957" x="116.038,122.536,126.532,130.528,133.525,136.027,140.527,142.777,143.857,147.853,150.355,152.857,155.107,156.187,159.688,164.188,168.688,171.19,175.186,179.182,181.684,185.185,187.435,188.515,191.512,196.012,200.512,208.009,211.006,213.256,214.336,220.834,223.336,225.838,230.338,232.588,233.668,240.67,245.17,247.672,250.174,252.676,257.176,259.678,263.674,265.924,267.004,270.505,274.501,277.003,280.999,283.996,288.496,291.997,294.499,298.0" svgx:width="0.72,0.44,0.44,0.33,0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Nearly all subjects (93%) with multiple sclerosis </text>
   <text y="570.955" x="62.362,65.359,73.36,78.364,81.361,83.674,87.67,92.17,96.67,100.666,103.663,106.165,110.161,114.661,118.657,122.653,124.966,128.467,132.967,139.969,143.965,146.278,150.778,154.774,159.274,162.271,166.267,170.263,172.576,177.076,180.073,182.386,189.388,193.888,198.388,200.89,203.392,205.894,208.396,212.896,215.209,217.711,224.713,229.213,233.209,235.711,238.708,245.71,249.706,254.206,256.708,265.708,270.208,274.708,278.704,281.701,284.014,288.514,292.51,295.012,298.009" svgx:width="0.33,0.89,0.56,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.39,0.5,0.78,0.44,0.25,0.5,0.44,0.5,0.33,0.44,0.44,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,1.0,0.5,0.5,0.44,0.33,0.25,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(MS) experience some degree of mobility impairment—over half </text>
   <text y="581.953" x="62.362,65.359,69.859,74.359,81.856,84.853,87.103,88.192,90.694,95.194,97.444,98.533,101.035,105.535,109.531,111.781,112.87,115.867,118.369,121.366,124.867,127.369,129.619,130.708,135.208,139.204,143.2,146.197,148.447,149.536,152.533,157.033,159.535,162.037,166.537,173.035,175.537,180.037,184.537,186.787,187.876,192.376,194.878,198.874,203.374,207.874,212.374,215.875,218.377,221.878,230.878,237.376,241.876,244.378,248.374,252.874,255.124,256.204,260.2,264.196,268.696,270.946,272.035,275.536,278.038,282.538,287.038,289.54,292.537,295.039" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,1.0,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(58%) in the first year following diagnosis—which can signifi-</text>
   <text y="592.951" x="62.362,66.358,70.354,74.854,77.356,79.858,84.358,86.419,90.919,93.421,100.423,102.925,107.425,109.927,113.428,117.928,119.989,124.489,128.485,132.481,134.983,137.485,141.985,144.982,147.979,151.975,154.477,158.473,160.975,164.971,169.471,171.532,176.032,180.532,184.528,187.03,189.532,192.034,196.534,198.595,203.095,206.092,208.153,210.655,213.157,216.154,220.15,222.4,224.461,229.96,234.46,238.96,242.956,247.456,251.956,255.952,260.452,262.513,269.011,271.513,275.014,279.01,283.51,286.012,288.514,291.016,293.518,298.018" svgx:width="0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.28,0.78,0.28,0.5,0.28,0.39,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.25,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cantly diminish health-related quality of life. Expanded Disability </text>
   <text y="603.949" x="62.362,67.366,69.868,73.864,76.366,80.866,84.367,86.284,91.288,95.284,99.28,101.782,105.778,107.695,110.692,116.191,122.689,127.693,132.697,135.694,137.611,140.113,143.614,145.531,150.031,154.531,158.527,160.444,167.446,171.442,175.438,178.939,183.439,186.436,190.432,192.349,196.849,201.349,203.851,205.768,210.268,214.264,216.766,220.762,224.758,227.26,230.761,232.678,236.674,241.174,245.674,247.591,252.091,256.591,260.587,265.087,267.589,270.091,273.088,275.59,279.586,283.087,285.004,287.506,291.502,294.004,298.0" svgx:width="0.56,0.28,0.44,0.28,0.5,0.39,0.25,0.56,0.44,0.44,0.28,0.44,0.25,0.33,0.61,0.72,0.56,0.56,0.33,0.25,0.28,0.39,0.25,0.5,0.5,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.39,0.25,0.28,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Status Scale (EDSS) is one measure but detects and quantifies late </text>
   <text y="614.947" x="62.362,65.863,68.365,72.361,76.861,80.857,83.107,85.699,92.701,97.201,101.701,104.203,106.705,109.207,111.709,116.209,118.459,121.051,123.553,130.555,135.055,139.051,141.553,144.55,151.552,155.548,160.048,162.55,164.8,167.05,169.147,175.15,177.4,179.992,183.493,185.995,189.991,193.987,197.983,202.483,204.985,208.981,211.231,213.823,218.323,221.32,225.82,230.32,234.82,237.817,240.319,242.821,247.321,251.821,254.071,256.663,261.163,264.16,266.41,269.002,272.503,277.003,281.503,284.005,288.001,291.997,294.499,298.0" svgx:width="0.39,0.28,0.44,0.5,0.44,0.25,0.55,0.78,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.72,0.25,0.55,0.39,0.28,0.44,0.44,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stage mobility impairment. A sizeable proportion of subjects </text>
   <text y="625.945" x="62.362,65.359,70.228,74.728,79.228,86.725,89.722,91.972,93.349,99.847,102.349,104.851,109.351,111.601,112.978,120.979,125.983,128.233,129.61,133.606,136.603,140.599,143.596,147.592,150.094,154.594,156.844,158.221,162.721,165.718,167.968,169.345,173.845,177.841,182.341,186.337,189.334,193.33,195.58,196.957,201.457,203.959,207.46,211.456,215.956,219.457,222.958,225.208,226.585,233.083,237.079,239.581,244.081,246.583,251.083,255.583,257.83299999999997,259.21,263.71,266.212,269.047,272.044,274.546,278.542,283.042,285.544,288.046,290.548,294.544,298.045" svgx:width="0.33,0.54,0.5,0.5,0.83,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.33,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.39,0.39,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.28,0.44,0.5,0.28,0.28,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(~40%) with MS “rarely or never” discuss walking difficulties </text>
   <text y="636.943" x="62.362,68.86,71.362,73.864,78.364,80.614,82.396,84.898,89.398,93.394,95.896,98.893,101.143,102.925,107.425,111.421,115.417,117.919,120.421,124.921,128.917,132.913,135.91,139.906,142.156,143.938,148.438,151.435,155.935,160.435,162.937,167.437,171.433,174.43,177.931,180.181,181.963,184.96,191.458,197.461,202.465,205.462,207.712,209.962,211.582,216.451,220.951,223.201,224.983,227.98,231.976,235.972,238.474,240.976,243.478,245.98,249.976,252.478,256.474,258.724,260.506,265.006,267.508,271.009,275.005,279.505,283.006,286.507,289.009,293.509,298.009" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.44,0.33,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.72,0.67,0.56,0.33,0.25,0.25,0.55,0.61,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.28,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with their healthcare providers (HCP). To facilitate discussion </text>
   <text y="647.941" x="62.362,66.862,70.858,73.36,79.858,83.854,87.85,92.35,94.897,98.398,102.898,107.398,109.9,113.896,117.892,120.394,123.895,126.442,132.94,135.442,137.944,142.444,144.991,152.992,157.996,160.543,164.539,169.039,173.539,176.086,178.588,183.088,187.084,189.586,192.583,195.13,201.628,207.631,212.635,216.136,218.386,220.933,224.929,229.429,233.929,236.476,238.978,245.98,250.48,253.477,257.977,262.477,266.473,269.02,271.522,276.022,280.018,284.518,287.02,289.522,292.519,295.021" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.72,0.67,0.56,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between subjects with MS and their HCPs, and improve identifi-</text>
   <text y="658.939" x="62.362,66.358,70.354,72.856,75.358,79.858,84.358,85.969,90.469,93.466,95.077,99.073,103.069,106.066,108.568,113.068,114.679,121.681,126.181,130.681,133.183,135.685,138.187,140.689,145.189,146.8,149.302,151.804,158.806,161.308,163.81,167.806,170.308,172.81,177.31,181.81,185.311,187.561,189.172,191.674,196.174,200.17,201.781,207.28,211.276,214.273,216.775,221.275,222.886,230.887,235.387,239.887,242.389,244.891,247.393,249.895,254.395,256.006,259.003,266.005,270.505,274.501,277.003,280.0,287.002,290.998,295.498,298.0" svgx:width="0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.28,0.5,0.25,0.78,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.28,0.5,0.44,0.25,0.61,0.44,0.33,0.28,0.5,0.25,0.89,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.33,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cation of early mobility limitations, the Early Mobility Impairment </text>
   <text y="669.937" x="62.362,68.86,73.36,77.356,80.857,83.359,85.861,90.361,94.861,99.361,103.357,105.859,108.856,112.852,115.102,119.134,122.131,127.63,135.631,138.628,145.126,148.123,150.373,154.405,160.903,164.899,168.4,170.65,174.682,179.182,183.178,187.678,191.674,194.176,198.676,203.176,207.172,211.672,213.922,217.954,222.454,226.45,229.951,233.947,238.447,240.697,244.729,249.229,253.729,255.979,260.011,264.511,269.011,273.007,275.509,278.011,280.513,284.509,287.011,289.513,294.013,298.009" svgx:width="0.72,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.55,0.33,0.61,0.89,0.33,0.72,0.33,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Questionnaire (EMIQ) was developed based on qualitative </text>
   <text y="680.935" x="62.362,65.359,69.355,72.856,76.852,80.848,83.845,87.841,92.341,94.96,97.462,101.962,104.581,109.081,113.077,115.579,118.081,122.077,126.577,129.079,132.58,135.199,141.697,144.199,146.701,151.201,153.82,161.821,166.825,169.444,173.44,177.94,182.44,185.059,187.561,192.061,194.68,198.676,203.176,205.678,208.18,212.176,216.676,221.176,224.173,228.169,230.671,233.173,237.673,242.173,244.792,251.29,253.792,256.294,260.794,263.413,267.913,271.909,276.409,279.028,283.528,288.028,290.53,295.03" svgx:width="0.33,0.44,0.39,0.44,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.25,0.5,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">research in patients with MS and in collaboration with key opin-</text>
   <text y="691.933" x="62.362,64.864,69.364,73.864,76.114,78.616,82.612,86.608,91.108,95.104,98.101,101.602" svgx:width="0.28,0.5,0.5,0.25,0.28,0.44,0.44,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ion leaders.</text>
   <text y="702.931" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="702.931" x="111.394,116.263,120.763,123.013,126.307,130.303,134.803,138.799,141.301,145.801,149.797,152.299,156.295,158.545,161.839,164.341,168.841,172.837,175.087,178.381,182.881,186.382,190.882,194.878,199.378,203.878,210.88,214.876,217.378,220.375,222.877,226.873,229.123,232.417,236.917,239.914,244.414,248.914,252.91,255.907,258.409,260.911,264.907,268.408,270.658,273.952,278.452,281.449,283.699,286.993,289.495,293.995,297.991" svgx:width="0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate the psychometric properties of the </text>
   <text y="713.929" x="62.362,66.862,71.362,74.359,76.861,79.363,83.359,90.361,92.611,94.285,99.784,107.785,110.782,117.28,119.53,121.78,123.454,125.956,130.456,134.452,136.954,141.454,145.954,148.456,152.956,157.456,159.706,161.38,165.88,169.876,172.873,175.375,179.875,183.871,186.373,188.875,193.375,197.875,200.125,201.799,206.299,209.296,211.546,213.22,217.216,219.466,221.14,224.641,228.637,233.137,236.134,238.636,243.136,247.636,249.886,251.56,255.556,258.058,262.558,267.058,270.055,272.557,275.059,279.559,286.561,288.811,290.485,294.481,297.982" svgx:width="0.5,0.5,0.33,0.28,0.28,0.44,0.78,0.25,0.55,0.61,0.89,0.33,0.72,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.25,0.55,0.39,0.44,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.28,0.5,0.5,0.33,0.28,0.28,0.5,0.78,0.25,0.55,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">15-item EMIQ, including derivation of a scoring algorithm as </text>
   <text y="724.927" x="62.362,68.86,72.856,75.358,77.86,80.11,84.106,87.607,89.857,93.853,96.355,98.857,103.357,105.859,109.855,113.851,116.353,118.603,121.105,125.605,128.602,132.598,136.099,140.599,145.099,147.601,152.101,155.602,157.852,160.849,165.349,168.346,170.596,174.097,178.597,183.097,185.599,189.595,193.591,196.093,198.343,201.844,205.84,208.837,212.833,216.829,221.329,223.831,228.331,232.831" svgx:width="0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.39,0.25,0.33,0.5,0.33,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">well as clinical thresholds for subject screening.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 413.160 L332.250 413.160 "/>
  <g begin="text">
   <text y="76.959" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="76.959" x="348.959,354.458,358.958,362.954,365.402,367.904,372.404,375.905,378.407,381.404,385.904,392.906,396.902,401.402,403.904,406.406,409.907,412.355,416.855,420.356,424.856,428.852,433.352,437.852,444.854,448.85,451.352,454.349,456.851,460.847,463.295,467.795,471.791,474.788,477.785,482.285,485.282,492.284,496.28,500.78,504.776,508.772,511.22,517.718,521.714,525.215,527.663,531.659,536.159,540.155,542.657" svgx:width="0.61,0.5,0.44,0.25,0.28,0.5,0.39,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.33,0.39,0.25,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.44,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The instrument’s psychometric performance was eval-</text>
   <text y="87.957" x="310.016,314.516,318.512,321.014,325.01,329.51,331.76,332.516,335.018,339.518,341.768,342.524,346.52,348.77,349.526,356.528,361.028,363.53,366.032,368.534,371.531,375.527,379.523,384.023,386.525,390.521,393.158,395.408,397.658,398.414,402.914,405.911,410.411,413.912,418.412,422.408,426.404,428.906,431.408,435.908,439.904,442.154,444.404,445.16,449.66,454.16,458.66,461.657,464.159,468.659,471.161,475.157,478.154,482.654,486.65,491.15,493.652,496.154,500.654,505.154,509.15,511.652,513.902,514.658,519.158,523.658,527.159,531.155,534.152,538.652,542.648" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.25,0.55,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.5,0.5,0.33,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">uated in a multi-center, prospective, non-interventional observa-</text>
   <text y="98.955" x="310.016,312.518,315.02,319.52,324.02,328.016,330.518,332.768,334.442,337.943,340.445,344.945,349.445,353.36,355.61,357.86,359.534,364.538,369.038,373.538,376.04,380.036,384.032,386.534,390.035,392.285,393.959,400.457,402.959,405.461,409.961,412.211,413.885,421.886,426.89,429.14,430.814,437.312,441.812,446.312,448.562,450.236,456.734,460.73,463.727,467.723,469.973,471.647,476.147,480.647,483.644,488.144,492.644,494.894,496.568,501.068,505.064,509.06,512.057,515.558,517.808,519.482,523.982,526.979,529.229,530.903,534.899,539.399,543.395,545.645" svgx:width="0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tional study. Subjects with MS who were 18-65 years of age, </text>
   <text y="109.953" x="310.016,313.517,318.017,322.517,327.017,331.013,333.344,338.843,343.343,347.843,350.345,352.847,356.348,360.848,363.098,365.429,369.425,373.925,378.425,380.756,385.256,389.252,393.752,396.083,400.079,404.579,406.91,412.409,418.907,423.911,428.915,431.246,434.747,438.743,443.243,446.24,450.236,452.567,457.067,460.064,462.395,466.895,469.145,473.645,475.976,478.478,482.978,485.309,489.809,492.059,496.559,498.89,505.388,509.384,512.381,516.377,518.708,522.704,525.206,527.708,532.208,534.71,539.21,541.712,545.708" svgx:width="0.39,0.5,0.5,0.5,0.44,0.25,0.61,0.5,0.5,0.28,0.28,0.39,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">spoke English, and had an EDSS score of 2.0 to 6.0 were eligible </text>
   <text y="120.951" x="310.016,312.518,317.018,319.574,324.074,328.07,331.067,333.569,336.071,340.067,342.569,347.069,351.065,353.567,357.563,359.813,362.369,367.373,371.873,376.373,378.875,382.871,386.867,389.369,392.87,395.426,399.422,403.922,410.924,415.424,417.926,421.922,424.424,428.42,432.92,435.476,439.472,442.028,445.529,449.525,452.522,455.024,459.02,462.521,465.077,469.577,472.574,475.13,479.63,484.13,488.126,491.627,494.129,496.631,501.131,505.631,510.131,514.127,516.629,519.626,523.622,527.123,529.679,534.179,538.679,542.675,545.672" svgx:width="0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.25,0.56,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.25,0.39,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.39,0.25,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to participate. Subjects completed a series of questionnaires over </text>
   <text y="131.949" x="310.016,312.518,319.016,323.516,325.325,328.826,331.328,335.828,340.328,344.828,346.637,351.137,353.639,357.14,359.642,362.144,365.645,367.454,371.954,376.454,380.45,382.259,388.757,392.753,396.749,401.249,403.058,407.054,411.554,415.55,418.547,421.049,423.299,425.108,428.105,432.605,434.414,438.41,442.91,447.41,449.912,452.414,454.916,459.416,463.916,465.725,468.227,472.727,474.536,478.532,483.032,484.841,487.343,489.845,493.841,500.843,503.84,506.342,510.338,514.838,518.834,521.336,523.145,527.141,531.641,535.637,538.139,542.639" svgx:width="0.28,0.72,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.28,0.39,0.28,0.28,0.39,0.25,0.5,0.5,0.44,0.25,0.72,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.33,0.28,0.25,0.25,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.25,0.28,0.28,0.44,0.78,0.33,0.28,0.44,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">two study visits one week apart. In addition to an item-level analy-</text>
   <text y="142.947" x="310.016,313.517,316.019,319.52,321.455,325.451,329.951,334.451,336.386,339.887,344.387,348.887,352.388,356.384,360.884,365.384,369.38,373.88,376.382,378.317,380.819,383.321,387.317,394.319,396.254,399.251,403.247,407.747,412.247,416.243,418.745,421.247,425.747,430.247,432.182,436.682,440.183,442.685,447.185,451.685,453.62,458.12,460.622,464.123,468.119,471.116,473.618,480.62,483.122,487.622,491.618,496.118,498.62,500.555,505.055,509.051,511.553,514.055,518.555,521.057,523.559,527.474,529.724,531.659,534.656,538.652,542.648" svgx:width="0.39,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.28,0.28,0.44,0.78,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.33,0.28,0.78,0.28,0.5,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sis and subsequent item reduction using discriminant validity, fac-</text>
   <text y="153.945" x="310.016,312.518,317.018,320.015,322.265,323.318,327.314,331.814,335.81,338.312,342.812,346.313,348.815,352.316,354.566,356.816,357.878,361.874,366.374,370.874,373.124,374.177,376.679,379.181,383.177,390.179,392.429,393.491,396.488,400.484,403.985,408.485,412.985,417.485,420.986,424.982,427.232,428.285,430.787,435.287,439.283,443.783,446.78,450.695,452.945,455.195,456.257,460.253,462.503,463.556,467.057,471.053,475.553,478.55,481.052,485.552,490.052,492.302,493.364,497.36,499.862,504.362,508.862,511.859,514.361,516.863,521.363,528.365,530.615,531.668,538.166,542.162,545.663" svgx:width="0.28,0.5,0.33,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.28,0.44,0.78,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.33,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.39,0.44,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.28,0.5,0.5,0.33,0.28,0.28,0.5,0.78,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tor analysis, and item response theory, a scoring algorithm was </text>
   <text y="164.943" x="310.016,314.516,318.512,323.012,327.008,329.51,334.01,338.51,342.506,347.006,349.256,351.704,355.7,360.2,364.7,366.95,369.398,371.9,376.4,380.396,382.646,385.094,387.596,392.096,395.597,398.099,401.096,405.596,412.598,416.594,421.094,423.596,426.098,429.599,431.849,434.297,438.797,442.298,446.798,450.794,455.294,459.794,466.796,470.792,473.294,476.291,478.793,482.789,485.039,487.487,491.987,494.984,499.484,503.984,507.98,510.977,513.479,515.981,519.977,523.478,525.728,528.176,534.674,538.67,541.667,545.663" svgx:width="0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.39,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.33,0.39,0.25,0.55,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">developed and the instrument’s psychometric properties were </text>
   <text y="175.941" x="310.016,314.012,318.512,322.508,325.01,329.51,333.506,336.008,340.004,344.504" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evaluated.</text>
   <text y="186.939" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="186.939" x="342.956,345.953,350.453,352.397,354.899,359.399,361.901,365.897,368.399,370.649,372.593,377.093,381.593,386.093,388.037,391.538,396.038,400.538,403.04,407.036,411.032,413.534,417.035,418.979,425.477,429.473,432.47,436.466,438.41,440.912,445.412,449.408,451.91,456.41,460.91,464.906,469.406,471.35,473.852,478.352,480.296,482.798,487.298,491.294,493.238,496.739,499.241,503.741,508.241,512.741,514.685,517.682,524.684,528.68,531.182,535.178,538.679,540.623,545.699" svgx:width="0.33,0.5,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.25,0.5,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.33,0.78,0.44,0.28,0.44,0.39,0.25,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In total, 124 subjects were included in the study [males = </text>
   <text y="197.937" x="310.016,314.516,319.016,326.513,329.015,331.517,335.513,340.013,344.009,346.511,349.508,356.51,360.506,364.502,369.002,371.999,374.501,379.577,382.079,386.579,391.079,393.581,398.081,402.077,406.073,409.07,412.571,415.073,417.575,421.571,426.071,430.571,433.073,438.572,445.07,450.074,455.078,457.58,461.081,465.077,469.577,472.574,476.57,479.072,482.069,489.071,493.067,497.063,501.563,504.56,507.062,512.138,514.64,519.14,521.39,525.89,528.887,531.137,533.639,538.643,541.145,545.645" svgx:width="0.5,0.5,0.83,0.28,0.25,0.44,0.5,0.44,0.25,0.33,0.78,0.44,0.44,0.5,0.33,0.25,0.56,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.28,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.33,0.78,0.44,0.44,0.5,0.33,0.25,0.56,0.25,0.5,0.25,0.5,0.33,0.25,0.25,0.56,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">23%; age (mean) = 52 years; and EDSS score (mean) = 4.2]. Six </text>
   <text y="208.935" x="310.016,312.518,315.02,319.016,326.018,329.519,331.769,332.471,338.969,342.965,345.962,349.958,352.208,352.91,355.412,359.912,363.908,368.408,370.91,373.412,376.409,378.911,382.907,387.407,389.657,390.359,393.356,397.856,400.853,403.103,403.805,407.801,410.303,412.805,419.807,422.309,426.809,430.805,433.307,435.809,440.309,444.809,447.059,449.849,455.348,459.848,463.844,466.094,466.796,469.793,473.789,477.29,481.79,484.292,486.794,489.296,493.796,498.296,500.546,501.248,505.748,508.745,511.247,513.749,517.745,524.747,526.997,527.699,531.2,535.196,539.192,541.694,545.69" svgx:width="0.28,0.28,0.44,0.78,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.28,0.28,0.44,0.78,0.25,0.55,0.39,0.44,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">items were identified for elimination. The resulting 9-item scale </text>
   <text y="219.933" x="310.016,314.516,318.512,323.012,325.262,327.251,331.751,336.251,340.247,342.497,344.486,347.987,350.489,353.486,357.986,362.486,366.986,369.236,371.225,375.725,380.225,384.725,388.721,391.718,394.22,398.72,401.222,405.722,410.222,412.472,414.461,418.961,423.461,430.463,434.459,436.961,441.461,443.711,445.7,448.697,451.694,454.196,457.193,460.694,463.196,465.446,467.435,471.431,473.933,478.433,482.429,486.929,491.429,495.425,497.927,502.427,506.423,508.673,510.662,514.658,519.158,523.658,526.16,530.156,532.658,537.158,541.154,545.654" svgx:width="0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.39,0.28,0.33,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.28,0.5,0.25,0.55,0.33,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.44,0.28,0.5,0.44,0.5,0.5,0.44,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">had one strong underlying domain (first eigenvalue explained </text>
   <text y="230.931" x="310.016,314.516,319.016,326.513,328.763,330.392,334.892,337.889,340.139,341.768,346.268,350.264,353.261,355.763,359.759,364.259,368.255,372.251,375.248,377.498,379.748,381.377,385.373,389.873,394.373,396.623,398.252,400.754,405.254,409.25,411.5,413.129,416.126,420.122,427.124,431.12,433.622,438.122,440.624,445.124,449.624,451.874,453.503,456.005,458.507,462.503,469.505,471.755,473.384,476.885,480.881,483.383,485.633,487.262,491.762,494.759,499.259,503.759,506.261,510.761,514.757,519.257,521.507,523.136,526.637,529.139,532.136,536.636,541.136,545.636" svgx:width="0.5,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.28,0.44,0.78,0.25,0.55,0.39,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">60% of variance), and the remaining item set provided strong </text>
   <text y="241.929" x="310.016,312.518,317.018,320.015,324.515,327.512,334.514,338.51,341.012,343.514,348.014,352.514,354.764,357.887,361.883,365.879,368.876,373.376,376.877,380.378,382.628,385.751,388.253,392.753,396.749,398.999,402.122,408.62,413.12,417.62,420.122,424.118,426.368,429.491,432.488,436.484,440.984,445.484,449.48,451.73,454.853,459.353,462.35,464.6,467.723,470.225,474.725,478.721,480.971,484.094,487.595,491.591,495.587,498.089,502.085,504.335,507.458,510.455,513.452,518.528,523.028,525.278,529.778,532.028,535.151,538.148,542.648,545.645" svgx:width="0.28,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.5,0.28,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.56,0.5,0.25,0.5,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">information across the whole range of the scale (I&gt;3.3 for </text>
   <text y="252.927" x="310.016,313.013,317.513,319.763" svgx:width="0.33,0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-2.6</text>
   <text y="252.927" x="324.263" svgx:width="0.55" style="fill:rgb(0,0,0);font-family:SymbolMT;font-size:9.0px;stroke:none;">≤</text>
   <text y="252.927" x="329.204" svgx:width="0.48" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">θ</text>
   <text y="252.927" x="333.515" svgx:width="0.55" style="fill:rgb(0,0,0);font-family:SymbolMT;font-size:9.0px;stroke:none;">≤</text>
   <text y="252.927" x="338.456,342.956,345.206,349.706,352.703,354.953,357.284,362.783,367.283,371.279,373.772,376.769,379.271,383.771,387.767,390.269,392.762,398.261,406.262,409.259,415.757,418.25,424.748,428.744,432.245,434.738,437.735,442.235,446.735,451.235,455.735,458.228,460.73,465.23,467.723,472.223,476.219,479.216,482.213,486.713,489.71,496.712,499.205,505.703,509.699,512.201,514.703,517.196,521.696,525.197,529.697,533.693,538.193,542.693" svgx:width="0.5,0.25,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.33,0.28,0.5,0.44,0.28,0.25,0.61,0.89,0.33,0.72,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.25,0.72,0.44,0.28,0.28,0.25,0.5,0.39,0.5,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2.4). The final EMIQ was found to perform well psycho-</text>
   <text y="263.925" x="310.016,317.018,321.014,323.516,326.513,329.015,333.011,337.007,339.509,342.011,345.926,348.176,350.426,351.776,358.274,360.776,363.278,367.778,370.028,371.378,374.879,377.381,380.378,384.878,389.378,393.878,396.128,397.478,401.474,405.974,408.476,412.976,416.972,421.472,425.468,429.464,431.714,433.064,437.564,440.561,442.811,444.161,446.663,450.659,454.16,456.662,459.659,462.656,466.652,469.154,473.15,476.651,479.153,481.403,482.753,485.75,488.747,494.75,500.753,505.829,510.329,512.579,517.079,521.579,526.079,529.076,531.326,532.676,536.672,541.172,545.672" svgx:width="0.78,0.44,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.33,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.44,0.39,0.28,0.33,0.33,0.44,0.28,0.44,0.39,0.28,0.25,0.55,0.33,0.33,0.67,0.67,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">metrically, with strong evidence of test-retest (ICC=0.858) and </text>
   <text y="274.923" x="310.016,312.518,317.018,319.52,323.516,326.513,331.013,335.009,337.511,339.761,341.795,345.791,350.291,354.791,358.292,360.794,364.295,366.797,370.793,375.293,379.289,383.789,386.039,388.073,391.07,395.786,400.862,405.362,407.612,412.112,416.612,421.112,424.109,426.359,428.393,431.39,435.386,437.888,440.39,444.386,448.886,451.388,453.89,456.392,458.894,462.809,465.059,467.309,469.343,473.339,476.84,479.09,481.124,487.622,491.618,494.12,496.622,498.872,500.906,504.902,508.403,510.653,512.687,516.683,521.183,525.683,529.184,531.686,534.683,539.183,543.179,545.681" svgx:width="0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.33,0.52,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.55,0.44,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.33,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">internal consistency (α=0.893) reliability, as well as construct </text>
   <text y="285.921" x="310.016,313.013,320.015,324.515,327.017,329.519,332.021,335.018,337.52,340.517,344.513,347.015,349.517,352.019,354.269,357.167,360.164,365.24,369.74,371.99,376.49,378.992,381.242,384.14,388.64,393.14,397.64,404.138,408.638,410.888,413.786,418.286,421.283,425.783,430.283,434.783,438.284,440.786,443.036,445.934,450.434,455.51,457.76,460.658,465.158,467.408,471.908,476.408,480.908,483.905,486.155,489.053,493.049,497.549,502.049,504.299,507.197,511.193,515.693,520.193,524.189,528.689,531.686,534.683,538.679,543.179,545.681" svgx:width="0.33,0.78,0.5,0.28,0.28,0.28,0.33,0.28,0.33,0.44,0.28,0.28,0.28,0.25,0.55,0.33,0.56,0.5,0.25,0.5,0.28,0.25,0.55,0.5,0.5,0.5,0.72,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.28,0.25,0.55,0.5,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(multi-trait: r&gt;0.4; known groups: p&lt; 0.001) and concurrent </text>
   <text y="296.919" x="310.016,313.013,316.01,321.086,325.586,327.836,332.336,336.836,339.833,342.083,346.583,350.579,353.081,355.583,360.083,362.585,365.087,369.002" svgx:width="0.33,0.33,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(r&gt;0.42) validity.</text>
   <text y="307.917" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="307.917" x="361.55,367.049,371.549,375.545,377.57,382.07,385.067,389.063,392.564,396.56,401.06,403.562,405.587,409.088,411.59,416.09,420.59,425.09,427.115,431.615,434.612,439.112,443.612,446.114,450.614,454.61,458.111,460.136,464.132,468.632,471.134,475.634,479.63,484.13,488.126,492.122,494.147,497.648,502.148,506.648,511.148,515.648,518.645,521.147,523.649,528.149,532.649,534.674,537.176,541.676,545.672" svgx:width="0.61,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The present study provides evidence supporting the </text>
   <text y="318.915" x="310.016,315.515,323.516,326.513,333.011,335.909,339.905,343.406,346.304,350.3,353.198,357.698,361.199,365.699,369.695,374.195,378.695,385.697,389.693,392.195,395.192,397.694,401.69,405.686,408.188,410.69,415.19,418.088,421.589,426.089,430.589,435.089,439.589,442.487,444.989,449.489,452.99,455.492,458.489,462.989,469.991,473.987,478.487,480.989,483.887,486.884,491.384,494.381,497.279,499.781,504.281,508.277,511.175,514.676,518.672,521.669,525.665,529.661,534.161,536.663,541.163,545.663" svgx:width="0.61,0.89,0.33,0.72,0.25,0.44,0.39,0.25,0.44,0.25,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.39,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EMIQ as a psychometrically sound instrument for the screening </text>
   <text y="329.913" x="310.016,314.516,317.513,319.763,320.501,324.002,328.502,333.002,335.504,339.5,343.496,345.998,349.499,351.749,352.487,356.483,360.983,365.483,369.479,372.476,374.978,378.974,383.474,387.47,389.972,394.472,398.972,401.222,401.96,405.956,409.952,412.949,415.451,419.951,422.201,422.939,429.941,434.441,438.941,441.443,443.945,446.447,448.949,453.449,455.699,456.437,458.939,465.941,470.441,474.437,476.939,479.936,486.938,490.934,495.434,497.936,501.437,503.687,504.425,508.925,513.425,517.421,519.671,520.409,522.911,527.411,529.661,530.399,538.4,543.404,545.654" svgx:width="0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.33,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of subjects experiencing early mobility impairments due to MS, </text>
   <text y="340.911" x="310.016,312.518,316.514,321.014,323.516,328.016,332.516,334.802,337.304,341.804,345.8,348.095,352.595,355.592,360.092,364.592,369.092,373.592,380.09,384.59,387.587,392.087,394.373,397.37,401.87,404.867,407.153,409.655,412.157,415.658,417.944,422.444,425.945,429.941,432.227,434.729,439.229,441.524,445.52,448.022,450.524,455.024,457.526,461.522,465.518,468.02,470.306,474.806,477.803,481.799,485.795,488.297,490.799,494.795,498.791,501.077,505.073,509.573,514.073,516.368,520.364,522.65,527.15,531.65,534.152,538.148,542.648" svgx:width="0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.5,0.72,0.5,0.33,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.28,0.39,0.25,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">laying the groundwork for its use in clinical practice and a poten-</text>
   <text y="351.909" x="310.016,312.518,315.02,319.016,321.518,323.768,326.765,331.265,333.767,337.763,340.013,342.515,347.015,349.265,353.765,358.265,360.767,365.267,367.769,372.269,376.769,379.019,383.015,385.517,388.019,392.519,395.021,399.017,403.013,405.515,407.765,411.761,415.262,418.763,422.759,426.26,429.761,436.763,440.759,445.259,447.761,450.011,454.007,458.507,463.007,465.257,467.759,472.259,474.761,478.757,481.754,486.254,490.25,494.75,497.252,499.754,504.254,508.754" svgx:width="0.28,0.28,0.44,0.28,0.25,0.33,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tial role in guiding clinical assessment and intervention.</text>
   <text y="378.909" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P785</text>
   <text y="389.907" x="310.016,316.019,320.519,325.019,327.521,332.525,337.025,340.022,342.524,347.024,352.028,354.278,358.778,361.775,364.025,369.029,373.529,376.526,379.028,383.024,388.028,391.025,393.275,398.279,402.275,406.775,409.277,412.274,417.278,419.528,423.029,426.026,430.526,433.523,438.527,442.028,444.278,446.78,451.784,454.034,457.031,462.035,466.031,468.281,473.78,480.278,483.275,486.272,490.772,498.269,503.273,507.269,509.771,514.775,517.277,522.281,526.277" svgx:width="0.67,0.5,0.5,0.28,0.56,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.25,0.56,0.44,0.5,0.28,0.33,0.56,0.25,0.39,0.33,0.5,0.33,0.56,0.39,0.25,0.28,0.56,0.25,0.33,0.56,0.44,0.25,0.61,0.72,0.33,0.33,0.5,0.83,0.56,0.44,0.28,0.56,0.28,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Evaluation of patient health status in the PR-fampridine </text>
   <text y="400.905" x="310.016,316.019,322.517,329.015,335.018,341.021,347.024,349.274,352.775,355.772,360.776,365.78,370.28,372.53,377.534,381.035,383.537,388.541,393.041,395.291,400.295,405.794,408.791,413.291,417.791,420.788,425.792,429.788,433.784,436.286,440.786,444.782,449.786,452.036,457.04,460.037,462.539,465.041,467.543,470.54,475.04,477.29,480.791,484.787,489.287,493.283,497.279" svgx:width="0.67,0.72,0.72,0.67,0.67,0.67,0.25,0.39,0.33,0.56,0.56,0.5,0.25,0.56,0.39,0.28,0.56,0.5,0.25,0.56,0.61,0.33,0.5,0.5,0.33,0.56,0.44,0.44,0.28,0.5,0.44,0.56,0.25,0.56,0.33,0.28,0.28,0.28,0.33,0.5,0.25,0.39,0.44,0.5,0.44,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">ENABLE study using SF-36-derived utility scores</text>
   <text y="411.903" x="310.016,316.514,318.764,324.263,328.259" svgx:width="0.72,0.25,0.61,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Lee</text>
   <text y="409.439" x="332.254" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="411.959" x="335.179,337.429,339.679,344.683,346.933,355.429,359.425,363.925" svgx:width="0.25,0.25,0.56,0.25,0.94,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Wang</text>
   <text y="409.439" x="368.425" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="411.959" x="371.35,373.6,375.85,383.851,386.101,392.599,396.595" svgx:width="0.25,0.25,0.89,0.25,0.72,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Yeh</text>
   <text y="409.439" x="401.095" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="420.437" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="422.959" x="312.941,318.44,320.942,325.442,329.942,333.938,338.438,340.688,343.685,348.185,352.181,356.177,358.427,360.677,366.68,371.18,377.678,382.178,385.679,388.181,392.681,397.181,401.177,403.427,405.677,413.174,418.673,420.923,423.173,429.671,434.171,436.673,439.175,443.171,447.671,449.921,454.421,456.923,461.423,463.925,467.921" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Cambridge, MA, United States</text>
   <text y="449.959" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="449.959" x="362.936,367.94,370.937,375.437,377.939,382.439,386.939,391.439,395.435,399.935,402.932,405.929,409.925,412.427,416.423,420.419,423.92,427.916,430.481,433.478,438.482,444.485,447.482,450.056,453.053,457.049,464.051,468.551,471.548,474.05,478.55,481.052,485.552,489.548,492.122,494.624,498.62,503.12,505.622,509.618,512.12,514.685,517.682,522.182,526.178,528.68,531.677,535.673,542.675" svgx:width="0.56,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.33,0.56,0.67,0.33,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.28,0.44,0.28,0.25,0.33,0.5,0.44,0.28,0.33,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Prolonged-release (PR) fampridine tablet (dalfam-</text>
   <text y="460.957" x="310.016,314.516,317.513,320.015,324.515,327.017,331.517,335.513,337.763,338.537,342.533,347.033,349.535,353.531,358.031,362.531,366.527,371.027,373.277,374.051,377.048,381.044,383.546,387.542,391.538,395.039,399.035,401.285,402.059,404.561,408.557,413.057,415.559,419.555,422.057,425.558,427.808,428.582,431.084,435.584,437.834,438.608,441.11,445.61,449.606,451.856,452.63,459.128,464.132,467.129,469.379,470.153,472.655,479.657,484.157,487.154,491.654,496.154,500.15,503.651,505.901,506.675,513.173,517.169,519.671,524.171,526.673,531.173,535.673,537.923,538.697,541.199,545.699" svgx:width="0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.28,0.44,0.5,0.28,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.33,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.39,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pridine extended release tablets in the US) improves walking in </text>
   <text y="471.955" x="310.016,318.017,323.021,324.965,329.465,333.461,335.963,338.465,342.461,346.961,349.463,352.964,355.214,357.158,362.657,369.155,375.653,381.656,387.155,392.654,394.598,397.595,402.095,406.595,410.096,414.092,417.089,421.589,425.585,428.087,430.589,435.089,439.589,443.585,446.087,448.031,451.532,454.034,458.534,463.034,467.534,470.531,472.475,476.471,480.971,484.967,487.469,491.969,495.965,498.467,502.463,506.963,508.907,511.409,515.909,519.905,521.849,525.845,528.68,531.677,535.673,539.669,542.171,545.672" svgx:width="0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.72,0.72,0.67,0.61,0.61,0.25,0.33,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS patients. ENABLE (observational study) evaluated the effects </text>
   <text y="482.953" x="310.016,314.516,317.513,319.763,320.645,325.145,329.645,331.895,332.777,339.275,343.271,347.267,351.767,355.268,357.599,359.849,360.731,363.233,366.23,370.226,374.222,376.724,383.726,387.722,392.222,394.724,396.974,397.856,404.354,406.856,409.358,413.858,416.108,416.99,421.994,427.997,430.994,433.991,437.987,444.989,449.489,452.486,454.988,459.488,461.99,466.49,470.486,472.736,473.618,476.615,481.115,485.615,487.865,488.747,495.749,500.249,502.499,503.381,505.883,512.381,514.883,518.879,522.875,525.125,526.007,530.507,534.503,537.005,539.507,543.422,545.672" svgx:width="0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.44,0.44,0.5,0.39,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.28,0.72,0.28,0.44,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of 48 weeks’ treatment with PR-fampridine (10 mg twice daily, </text>
   <text y="493.951" x="310.016,312.518,316.514,321.014,325.01,329.51,331.634,336.134,340.634,342.758,347.258,351.758,356.258,359.255,362.756,364.88,368.876,373.376,377.372,380.369,382.871,385.868,387.983,392.483,396.983,399.107,403.607,407.603,411.599,414.101,416.603,421.103,424.1,427.097,431.093,433.595,437.591,440.093,444.089,448.589,450.704,455.204,459.704,463.7,466.202,468.704,471.206,475.706,477.83,482.33,485.327,487.451,489.953,492.455,495.452,499.448,501.572,504.569,511.067,517.07,523.568,528.068,533.567,536.564,538.679,541.181,545.681" svgx:width="0.28,0.44,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.39,0.25,0.44,0.5,0.44,0.33,0.28,0.33,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.33,0.72,0.67,0.72,0.5,0.61,0.33,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">taken 12 hours apart) on health-related quality of life (HRQoL) in </text>
   <text y="504.949" x="310.016,318.017,323.021,325.406,329.906,333.902,336.404,338.906,342.902,347.402,349.904,353.405,355.79,362.288,364.79,367.292,371.792,374.177,380.675,384.671,387.173,391.673,394.175,398.675,403.175,405.56,408.062,415.064,419.564,423.56,426.062,429.059,436.061,440.057,444.557,447.059,449.309,451.694,457.697,462.197,469.199,473.699,478.199,481.7,484.202,486.704,490.7,493.085,499.583,505.586,512.084,516.584,521.75,524.135,528.635,531.137,533.639,536.141,538.643,541.145,545.645" svgx:width="0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.25,0.67,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.72,0.67,0.72,0.5,0.61,0.25,0.5,0.28,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS patients with walking impairment. Composite HRQoL utility </text>
   <text y="515.947" x="310.016,317.018,321.014,325.01,328.511,333.011,336.008,340.004,343.505,345.899,349.895,352.892,356.888,359.282,363.782,367.283,371.279,375.779,378.173,382.169,385.67,388.064,392.06,396.56,398.954,401.456,405.956,410.456,412.958,416.954,420.95,423.452,425.954,430.454,434.954,437.348,441.848,444.845,447.239,449.741,454.241,458.237,460.631,465.131,469.127,473.123,475.625,478.127,482.627,485.021,488.522,491.024,495.02,497.522,502.022,505.523,507.917,512.417,515.414,517.808,521.804,526.304,528.698,531.2,535.7,540.2,542.702" svgx:width="0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.25,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">measures are used as an indication of the health status of an indi-</text>
   <text y="526.945" x="310.016,314.516,317.018,321.518,326.018,330.014,332.516,334.766,338.762,341.264,343.514,347.51,349.76,354.26,358.256,361.253,363.755,366.257,370.253,374.753,377.255,381.251,384.248,386.498,389.0,391.502,398.504,402.5,404.75,409.25,413.75,416.252,420.752,423.254" svgx:width="0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.28,0.25,0.44,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.25,0.28,0.28,0.78,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vidual at a particular time point.</text>
   <text y="537.943" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="537.943" x="355.133,360.632,365.132,367.634,371.135,372.764,376.76,381.26,385.256,387.758,392.258,395.759,398.261,401.762,403.391,407.387,411.887,415.883,418.385,422.885,426.881,429.383,433.379,437.879,439.508,442.01,446.51,450.506,452.135,456.635,460.631,464.627,467.129,469.631,474.131,475.76,479.261,481.763,485.759,488.261,492.257,493.886,498.386,501.383,503.012,511.013,516.017,517.646,522.146,526.142,528.644,531.146,535.142,539.642,542.144,545.645" svgx:width="0.61,0.5,0.28,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This analysis evaluated the health state of MS patients </text>
   <text y="548.941" x="310.016,316.514,321.014,325.514,328.349,334.847,338.843,341.84,345.836,348.671,351.173,354.17,358.166,362.162,364.664,368.66,373.16,375.662,380.162,384.662,387.164,389.999,392.501,395.498,399.494,403.49,405.992,409.988,414.488,417.323,423.821,426.323,428.825,433.325,436.16,441.164,447.167,450.164,453.161,457.157,464.159,468.659,471.656,474.158,478.658,481.16,485.66,489.656,492.491,496.991,501.491,505.487,508.484,511.319,515.819,520.319,523.154,529.652,533.648,537.644,542.144,545.645" svgx:width="0.72,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.28,0.5,0.5,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">who were treated/not treated with PR-fampridine over 48 weeks </text>
   <text y="559.939" x="310.016,312.518,317.018,319.205,324.704,331.202,337.7,343.703,349.202,354.701,356.888,361.388,364.889,367.391,371.891,376.391,378.578,383.582,388.586,391.583,396.083,402.581,404.768,409.268,411.77,414.272,416.774,419.276,421.778,426.278,428.465,431.966,435.962,440.462,443.459,447.455,450.956,453.143,457.643,461.639,464.636,467.138,471.638,475.634,480.134,482.321,485.318,488.315,492.815,499.817,502.004,504.506,509.006,513.002,515.189,520.193,525.197,528.194,532.694,537.194,539.444,541.631,545.627" svgx:width="0.28,0.5,0.25,0.61,0.72,0.72,0.67,0.61,0.61,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.56,0.56,0.33,0.5,0.72,0.25,0.5,0.28,0.28,0.28,0.28,0.28,0.5,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.56,0.56,0.33,0.5,0.5,0.25,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in ENABLE using SF-6D utility scores derived from the SF-36, a </text>
   <text y="570.937" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,337.511,340.508,344.504,349.004,353.504,356.501,359.003,362.999,367.499,369.749,374.249,378.749,381.251,385.247,389.747,396.749,400.745,402.995,406.496,410.996,413.993,418.493,422.489,426.404" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.39,0.5,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patient-reported outcome survey.</text>
   <text y="581.935" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="581.935" x="351.065,354.062,358.562,360.812,363.116,368.615,375.113,381.611,387.614,393.113,398.612,400.862,403.112,405.416,413.417,418.421,420.671,422.975,427.475,431.471,433.973,436.475,440.471,444.971,447.473,450.974,453.224,455.528,458.525,463.025,467.525,470.522,475.022,479.522,481.772,484.076,488.576,491.573,493.823,496.127,502.625,505.127,507.629,512.129,514.379,516.683,523.181,527.177,529.679,534.179,536.681,541.181,545.681" svgx:width="0.33,0.5,0.25,0.55,0.61,0.72,0.72,0.67,0.61,0.61,0.25,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In ENABLE, MS patients (18-75 y) with walking </text>
   <text y="592.933" x="310.016,312.518,319.52,324.02,328.016,330.518,333.515,340.517,344.513,349.013,351.515,353.522,357.518,362.018,369.02,373.52,376.022,380.018,382.52,386.516,391.016,393.023,395.525,400.025,404.021,405.866,411.05,413.552,420.554,424.55,429.05,431.057,435.557,440.057,443.054,448.058,452.558,457.058,459.56,461.405,469.181,473.177,475.679,480.179,482.186,485.183,490.682,495.182,499.682,504.686,513.182,516.179,518.186,522.182,524.684,526.691,531.191,535.187,538.688,542.684" svgx:width="0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.61,0.28,0.78,0.44,0.5,0.25,0.5,0.5,0.33,0.56,0.5,0.5,0.28,0.25,0.94,0.44,0.28,0.5,0.25,0.33,0.61,0.5,0.5,0.56,0.94,0.33,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">impairment completed the Timed 25-Foot Walk (T25FW) at base-</text>
   <text y="603.931" x="310.016,312.518,315.02,319.52,323.516,325.676,329.672,334.172,338.672,340.67,348.446,352.442,356.438,360.938,364.439,366.599,371.099,373.259,377.255,381.755,386.255,388.415,392.915,395.075,399.071,403.571,408.071,410.231,412.733,417.233,421.229,423.389,431.39,436.394,438.392,446.168,450.164,452.666,457.166,459.668,464.168,468.668,470.828,475.832,479.828,483.824,486.326,490.322,492.482,495.479,503.48,508.484,516.98,521.984,524.981,529.481,533.981,536.978,539.138,543.134,545.636" svgx:width="0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.94,0.44,0.44,0.5,0.39,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.25,0.94,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.56,0.44,0.44,0.28,0.44,0.25,0.33,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.33,0.25,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line and Weeks 2 and 4 and the MS Walking Scale (MSWS-12) at </text>
   <text y="614.929" x="310.016,314.516,318.512,322.013,326.009,328.511,331.013,335.513,339.509,342.416,346.412,350.912,355.412,358.157,365.933,369.929,373.925,378.425,381.332,385.832,388.082,390.989,395.993,399.989,402.491,404.993,408.989,413.489,415.991,419.492,422.399,428.897,431.399,433.901,438.401,441.308,445.304,449.804,454.304,457.211,459.713,466.715,471.215,474.212,478.712,483.212,487.208,494.21,498.206,502.706,505.208,508.115,510.617,515.117,517.862,523.361,527.861,532.361,537.365,545.699" svgx:width="0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.94,0.44,0.44,0.5,0.25,0.5,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.61,0.5,0.5,0.56,0.94,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">baseline and Week 4. Patients with any improvement in T25FW </text>
   <text y="625.927" x="310.016,313.517,318.017,322.013,326.009,330.509,332.741,336.737,339.239,341.309,349.085,353.081,357.077,361.577,365.078,367.31,371.81,374.042,378.038,382.538,387.038,389.27,393.77,396.002,399.998,404.498,408.998,411.23,413.732,418.232,420.464,428.465,433.469,441.965,446.969,449.966,454.466,458.966,461.198,464.699,468.695,473.195,476.192,480.188,482.411,486.407,488.909,490.979,498.755,502.751,506.747,511.247,513.479,517.979,520.211,524.207,528.707,533.207,535.709,538.211,542.711" svgx:width="0.39,0.5,0.44,0.44,0.5,0.25,0.44,0.28,0.25,0.94,0.44,0.44,0.5,0.39,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.44,0.28,0.25,0.94,0.44,0.44,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">speed at Weeks 2 and 4 and in MSWS-12 score at Week 4 contin-</text>
   <text y="636.925" x="310.016,314.516,318.512,323.012,325.505,328.007,331.004,335.0,338.996,341.498,348.5,352.496,356.996,359.498,361.748,364.241,369.245,373.241,375.743,378.245,382.241,386.741,389.243,392.744,395.237,401.735,406.235,410.735,413.228,417.728,420.23,424.73,427.223,431.723,436.223,438.725,441.218,448.22,452.216,456.212,458.714,461.207,463.709,468.209,470.711,474.212,476.705,480.701,483.698,486.2,488.702,492.698,495.695,498.197,502.697,507.197,509.69,514.19,516.692,520.193,524.189,528.689,533.189,535.691,538.193,542.693" svgx:width="0.5,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.78,0.44,0.44,0.28,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ued treatment. Patients who did not meet this criterion discontin-</text>
   <text y="647.923" x="310.016,314.516,318.512,323.012,325.262,326.405,328.907,331.904,335.9,339.896,342.398,349.4,353.396,357.896,360.398,362.648,363.782,368.282,372.782,375.284,377.534,378.677,383.177,387.173,391.673,393.923,395.066,397.568,402.068,406.064,408.314,409.457,413.957,418.457,420.959,423.461,427.961,432.461,434.711,435.854,438.356,442.856,445.106,446.249,450.245,454.745,459.245,461.747,464.249,468.749,473.249,477.245,479.495,480.638,484.634,488.135,490.385,491.528,496.028,500.024,503.021,505.523,507.773,508.916,513.416,516.413,518.663,519.806,522.308,526.808,530.804,533.054,534.197,538.697,543.197,545.699" svgx:width="0.5,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.44,0.33,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ued treatment but had the option to continue as part of the not </text>
   <text y="658.921" x="310.016,312.518,315.515,319.511,323.507,326.009,330.005,334.505,336.755,338.051,342.047,346.547,351.047,353.549,356.546,361.046,363.548,365.798,367.094,371.594,374.591,379.091,383.591,388.091,390.341,392.591,393.887,398.891,403.895,406.892,411.392,415.892,418.142,419.438,422.435,426.935,431.435,434.432,436.682,437.978,444.476,448.472,451.973,454.223,455.519,459.515,463.016,466.517,470.513,474.014,477.515,481.511,486.011,488.261,489.557,493.553,496.055,498.305,499.601,504.101,508.097,511.598,515.594,518.096,520.598,525.098,529.094,531.344,532.64,536.636,541.136,545.636" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.56,0.33,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated control group. SF-36 (v2) was assessed at baseline and </text>
   <text y="669.919" x="310.016,317.792,321.788,325.784,330.284,333.785,335.639,340.139,344.639,346.889,348.743,353.243,357.743,359.993,361.847,366.347,370.847,373.097,374.951,378.947,383.447,387.947,389.801,394.301,398.801,401.051,402.743,408.242,412.742,416.738,418.592,423.596,428.6,431.597,436.097,442.595,444.449,448.949,451.946,455.942,458.939,462.935,465.932,469.928,474.428,478.424,482.42,485.417,489.917,493.913,497.414,501.41,505.91,507.764,511.76,514.262,518.762,523.262,526.259,528.761,531.263,535.763" svgx:width="0.94,0.44,0.44,0.5,0.39,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.56,0.56,0.33,0.5,0.72,0.25,0.5,0.33,0.44,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.44,0.28,0.5,0.5,0.33,0.28,0.28,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Weeks 12, 24, 36, and 48. The SF-6D preference-based algorithm</text>
   <text y="667.439" x="542.744" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="669.959" x="545.669" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="680.957" x="310.013,312.515,319.517,324.017,326.519,330.515,337.517,341.513,346.013,348.515,352.511,357.011,359.72,362.222,366.722,369.431,374.435,379.439,382.436,386.936,393.434,396.143,399.644,403.64,408.14,411.137,413.639,418.139,422.639,425.348,429.848,432.845,437.345,441.845,444.842,448.839,455.841,462.843,466.839,470.34,473.049,479.547,483.543,487.044,489.753,494.253,497.754,501.75,506.25,508.959,511.461,515.961,518.67,522.666,527.166,531.666,536.166,540.161,543.159,545.661" svgx:width="0.28,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.56,0.56,0.33,0.5,0.72,0.25,0.39,0.44,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.78,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">implemented in SF-6D scoring programmes was used to convert </text>
   <text y="691.955" x="310.013,315.017,320.021,323.018,327.518,332.018,334.268,336.428,340.928,344.924,347.426,351.422,353.672,355.832,358.334,362.834,365.336,369.836,372.086,374.246,379.25,384.254,387.251,391.751,398.249,400.499,402.659,407.159,411.155,413.657,417.653,419.903,422.063,428.561,433.061,435.563,439.559,444.059,446.309,448.469,452.465,456.965,461.465,463.967,467.963,470.465,474.965,478.466,480.716,482.876,487.376,489.626,491.786,495.287,499.283,503.783,506.78,510.776,513.0260000000001,515.186,519.686,524.186,531.188,535.184,537.686,542.186,545.687" svgx:width="0.56,0.56,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.56,0.56,0.33,0.5,0.72,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.5,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.25,0.55,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">SF-36 data into SF-6D data which contains 6 score domains </text>
   <text y="702.953" x="310.013,313.01,317.51,322.01,326.51,330.011,332.513,336.509,340.505,343.007,345.662,348.659,353.159,357.659,361.655,364.157,366.659,371.159,375.659,378.161,382.661,387.161,389.411,392.066,395.063,399.563,402.065,406.061,408.716,413.216,417.212,420.209,422.711,425.213,429.209,431.711,436.211,440.207,442.71,445.212,449.712,454.212,456.462,459.117,462.618,467.118,471.114,473.616,477.612,480.114,482.769,485.766,490.266,494.766,498.762,501.264,503.766,508.266,512.766,515.268,519.768,524.268,526.518,529.173,533.673,538.173,542.673" svgx:width="0.33,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.33,0.5,0.28,0.44,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.39,0.5,0.44,0.28,0.44,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(physical functioning, role participation, social functioning, bod-</text>
   <text y="713.951" x="310.013,312.515,315.017,319.517,321.767,323.477,327.977,331.973,334.475,338.975,341.225,343.475,345.185,352.187,356.183,360.683,363.185,367.181,369.683,371.933,373.643,378.143,382.139,386.135,388.637,391.139,395.639,397.889,400.139,401.849,406.349,408.851,411.353,415.349,417.851,420.353,422.855,427.355,430.352,432.602,434.312,438.308,442.808,447.308,449.558,451.268,455.768,459.764,463.76,466.262,468.764,473.264,475.514,477.224,480.725,483.228,487.224,489.726,493.722,495.972,497.682,502.182,504.684,507.186,509.688,512.19,514.692,519.192,521.442,523.152,526.653,530.649,535.149,538.146,542.142,545.643" svgx:width="0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.5,0.28,0.28,0.44,0.28,0.28,0.28,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ily pain, mental health, vitality) and health state utility scores </text>
   <text y="724.949" x="310.013,313.01,316.007,320.003,324.503,329.003,332.999,335.249,339.749,341.999,344.996,349.496,353.492,357.488,361.988,364.985,367.235,369.737,374.237,376.487,380.987,383.237,387.737,389.987,392.984,397.484,401.48,404.477,407.474,411.47,415.466,417.968,420.218,424.718,428.714,432.71,435.212,437.714,442.214,445.211,448.208" svgx:width="0.33,0.33,0.44,0.5,0.5,0.44,0.25,0.5,0.25,0.33,0.5,0.44,0.44,0.5,0.33,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(range 0 [dead] to 1.0 [perfect health]).</text>
  </g>
 </g>
</svg>
